Abstract
Chiarito M, Sanz-Sánchez J, Cannata F, et al. Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. Lancet. 2020;395;1487-95. 32386592.
MeSH terms
-
Aspirin / therapeutic use
-
Atherosclerosis* / drug therapy
-
Atherosclerosis* / prevention & control
-
Hemorrhage
-
Humans
-
Patients
-
Percutaneous Coronary Intervention*
-
Platelet Aggregation Inhibitors / adverse effects
-
Purinergic P2Y Receptor Antagonists / therapeutic use
-
Secondary Prevention
-
Stroke* / prevention & control
Substances
-
Platelet Aggregation Inhibitors
-
Purinergic P2Y Receptor Antagonists
-
Aspirin